INTERNATIONAL ZEOLITE CORP (IZ.CA) Stock Fundamental Analysis

TSX-V:IZ • CA4605821095

0.01 CAD
0 (0%)
Last: Nov 3, 2025, 07:00 PM
Fundamental Rating

1

IZ gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. IZ has a bad profitability rating. Also its financial health evaluation is rather negative. IZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • IZ had negative earnings in the past year.
  • IZ had a positive operating cash flow in the past year.
  • IZ had negative earnings in each of the past 5 years.
  • IZ had a negative operating cash flow in each of the past 5 years.
IZ.CA Yearly Net Income VS EBIT VS OCF VS FCFIZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA 0.66%
ROE N/A
ROIC N/A
ROA(3y)-113.55%
ROA(5y)-84.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IZ.CA Yearly ROA, ROE, ROICIZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • IZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.98%
PM (TTM) 0.41%
GM 43.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y0.61%
IZ.CA Yearly Profit, Operating, Gross MarginsIZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

  • IZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IZ has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IZ has been increased compared to 5 years ago.
  • Compared to 1 year ago, IZ has a worse debt to assets ratio.
IZ.CA Yearly Shares OutstandingIZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
IZ.CA Yearly Total Debt VS Total AssetsIZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

  • IZ has an Altman-Z score of -45.17. This is a bad value and indicates that IZ is not financially healthy and even has some risk of bankruptcy.
  • IZ has a debt to FCF ratio of 11.88. This is a negative value and a sign of low solvency as IZ would need 11.88 years to pay back of all of its debts.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.88
Altman-Z -45.17
ROIC/WACCN/A
WACC5.62%
IZ.CA Yearly LT Debt VS Equity VS FCFIZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that IZ may have some problems paying its short term obligations.
  • IZ has a Quick Ratio of 0.16. This is a bad value and indicates that IZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.12
IZ.CA Yearly Current Assets VS Current LiabilitesIZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 100.28% over the past year.
  • The Revenue has grown by 109.16% in the past year. This is a very strong growth!
  • IZ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.54% yearly.
EPS 1Y (TTM)100.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.57%
Revenue 1Y (TTM)109.16%
Revenue growth 3Y6.1%
Revenue growth 5Y-1.54%
Sales Q2Q%245.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IZ.CA Yearly Revenue VS EstimatesIZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
IZ.CA Price Earnings VS Forward Price EarningsIZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.25
EV/EBITDA 6.97
IZ.CA Per share dataIZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • IZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTERNATIONAL ZEOLITE CORP

TSX-V:IZ (11/3/2025, 7:00:00 PM)

0.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)10-22
Earnings (Next)11-26
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners19.78%
Ins Owner ChangeN/A
Market Cap424.10K
Revenue(TTM)1.08M
Net Income(TTM)4.40K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF 3.25
P/OCF 3.24
P/B N/A
P/tB N/A
EV/EBITDA 6.97
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY30.79%
OCF(TTM)0
OCFY30.82%
SpS0.03
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.66%
ROE N/A
ROCE -8.97%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 15.98%
PM (TTM) 0.41%
GM 43.05%
FCFM 12.06%
ROA(3y)-113.55%
ROA(5y)-84.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y0.61%
F-Score6
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.88
Debt/EBITDA 3.91
Cap/Depr 1.33%
Cap/Sales 0.01%
Interest Coverage 1.36
Cash Conversion 72.41%
Profit Quality 2968.18%
Current Ratio 0.16
Quick Ratio 0.12
Altman-Z -45.17
F-Score6
WACC5.62%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)8.13%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.16%
Revenue growth 3Y6.1%
Revenue growth 5Y-1.54%
Sales Q2Q%245.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y123.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.16%
OCF growth 3YN/A
OCF growth 5YN/A

INTERNATIONAL ZEOLITE CORP / IZ.CA FAQ

What is the fundamental rating for IZ stock?

ChartMill assigns a fundamental rating of 1 / 10 to IZ.CA.


What is the valuation status for IZ stock?

ChartMill assigns a valuation rating of 0 / 10 to INTERNATIONAL ZEOLITE CORP (IZ.CA). This can be considered as Overvalued.


Can you provide the profitability details for INTERNATIONAL ZEOLITE CORP?

INTERNATIONAL ZEOLITE CORP (IZ.CA) has a profitability rating of 1 / 10.


What is the financial health of INTERNATIONAL ZEOLITE CORP (IZ.CA) stock?

The financial health rating of INTERNATIONAL ZEOLITE CORP (IZ.CA) is 0 / 10.